Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids.

MLA

Park, Dongil, et al. “Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids.” Cells (2073-4409), vol. 12, no. 14, July 2023, p. 1854. EBSCOhost, https://doi.org/10.3390/cells12141854.

APA

Park, D., Lee, D., Kim, Y., Park, Y., Lee, Y.-J., Lee, J. E., Yeo, M.-K., Kang, M.-W., Chong, Y., Han, S. J., Choi, J., Park, J.-E., Koh, Y., Lee, J., Park, Y., Kim, R., Lee, J. S., Choi, J., Lee, S.-H., & Ku, B. (2023). Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids. Cells (2073-4409), 12(14), 1854. https://doi.org/10.3390/cells12141854

Chicago

Park, Dongil, Dahye Lee, Yoonjoo Kim, Yeonhee Park, Yeon-Jae Lee, Jeong Eun Lee, Min-Kyung Yeo, et al. 2023. “Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids.” Cells (2073-4409) 12 (14): 1854. doi:10.3390/cells12141854.